Canine Influenza Vaccine, H3N2, Killed VirusThis page contains information on Canine Influenza Vaccine, H3N2, Killed Virus for veterinary use.
The information provided typically includes the following:
- Canine Influenza Vaccine, H3N2, Killed Virus Indications
- Warnings and cautions for Canine Influenza Vaccine, H3N2, Killed Virus
- Direction and dosage information for Canine Influenza Vaccine, H3N2, Killed Virus
Canine Influenza Vaccine, H3N2, Killed VirusThis treatment applies to the following species:
For use by, or under the supervision of, a veterinarian.
This product license is conditional. Efficacy and potency studies are in progress.
For vaccination of healthy dogs as an aid in the control of disease associated with canine influenza (H3N2) virus infection.
Directions For Use
Vaccination of healthy dogs is recommended. Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs 8 weeks of age and older should receive 2 doses administered 3 weeks apart. Annual revaccination with a single dose is recommended.
PrecautionsStore at 2°-7°C (35°-45°F). Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze. Use entire contents when first opened. Sterilized syringes and needles should be used to administer this vaccine. Contains gentamicin as preservative.
Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (888) 963-8471 (USA), (800) 461-0917 (Canada).
For veterinary use only
U.S. Veterinary License No. 190
Zoetis Inc., Kalamazoo, MI 49007, USA
25 1-dose (1-mL) vials of vaccine
NAC No.: 3690518.0
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Canine Influenza Vaccine, H3N2, Killed Virus information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06